https://www.selleckchem.com/products/ml141.html
Men on GnRH antagonists showed increased risk of acute myocardial infarction (HR 1.62; 95% CI 1.11-2.35; I2 0%) and arrhythmia (HR 1.55; 95% CI 1.11-2.15, I2 17%) compared to GnRH agonists. Having a history of CVD was found to be an effect modifier for the associations with some CVD subtypes. Overall, we did not observe a difference in risk of overall CVD when comparing GnRH antagonists with agonists-though for some subtypes of CVD we noted an increased risk with antagonists. Further studies are required to address potential confounding c